Herantis Pharma Oyj
HLSE:HRTIS
1,61
€0,00 (0,00%)
1,61
€0,00 (0,00%)
End-of-day quote: 04/06/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

€-0,24
Earnings Per Share
€0,00
Revenue Per Share
0,00%
Gross Margin %
€0,04 B
Market Cap
€0,00 B
Long-Term Debt
Earnings Per Share
€-0,24
Revenue Per Share
€0,00
Gross Margin %
0,00%
Market Cap
€0,04 B
Long-Term Debt
€0,00 B

Financials

Year Year 2026 2025 2024 2020 2019 2018
EPS Earnings Per Share €-0,28 €-0,24 €-1,24 €-1,37 €-0,85
Earnings Earnings €-6,75M €-4,84M €-12,10M €-9,15M €-4,18M
RPS Revenue Per Share €0,00 €0,00 €0,00 €0,00 €0,00 €0,00
Revenue Revenue €0,00M €0,00M €0,00M €0,00M €0,00M €0,00M
OCF Operating Cash Flow €0,00M €-6,00M €-4,00M €-8,56M €-5,96M €0,00M
FCF Free Cash Flow €0,00M €-3,10M €-4,00M €-8,56M €-5,96M €0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 100,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share €0,00 €-0,26 €-0,32 €-1,16 €-1,02 €-0,76
LT Debt Long-Term Debt N/A €0,02M €0,02M €5,94M €7,21M €5,88M
Sha. Stocks 20,16M 24,09M 20,16M 9,76M 6,68M 4,92M
×